Literature DB >> 2295822

Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures.

D A Lebman1, F D Lee, R L Coffman.   

Abstract

Transforming growth factor beta (TGF-beta), but not IL-2, causes LPS-stimulated surface (s)IgA- cells to express sIgA. Although there is a progression of sIgA- cells to sIgA+ cells and then to IgA-secreting cells, there is not a parallel change in ratio of membrane to secreted form of alpha-mRNA. In fact, the secreted form of alpha-mRNA is always the predominant form even before the expression of sIgA. However, at least some of the secreted alpha-mRNA transcripts are sterile. The increase in sIgA expression and the induction of sterile transcripts indicate that TGF-beta enhances H chain class switching to IgA as opposed to allowing the growth and maturation of cells precommitted to IgA secretion. The addition of IL-2 to cultures with TGF-beta results in a 5- to 10-fold increase in IgA secretion compared to cultures to which only TGF-beta was added. In these cultures IL-2 increases neither the proportion nor the total number of sIgA+ cells suggesting that IL-2 acts to increase IgA secretion. However, IL-2 does not cause a change in the ratio of secreted to membrane form of alpha-mRNA nor does it lead to an increase in the steady state level of alpha-mRNA comparable to the increase in secreted IgA. Thus, it appears that regulation of transcription of IgA as sIgA- cells proliferate and undergo H class switching and maturation does not follow the same sequence as is seen when sIgM+ cells proliferate and mature to Ig-secreting cells. Furthermore, the data suggest that maturation to high level secretion is controlled posttranscriptionally.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Developmental regulation of immunoglobulin mRNA processing and the IgA response: establishing a paradigm.

Authors:  D A Lebman; J H Coyle
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 3.  A lay doctor's guide to the inflammatory process in the gastrointestinal tract.

Authors:  S Pathmakanthan; C J Hawkey
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

4.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

Authors:  H Fukaura; S C Kent; M J Pietrusewicz; S J Khoury; H L Weiner; D A Hafler
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

5.  Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.

Authors:  Masaki Terabe; Faith C Robertson; Katharine Clark; Emma De Ravin; Anja Bloom; David J Venzon; Shingo Kato; Amer Mirza; Jay A Berzofsky
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

6.  Transforming growth factor-beta in a model of IgA switching.

Authors:  D Y Kunimoto
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Regulation of the antibody class switch to IgA.

Authors:  Y C Lin; P Shockett; J Stavnezer
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

8.  Early steps of IgA B cell differentiation.

Authors:  W Strober; G R Harriman; D R Kunimoto
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

9.  Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions.

Authors:  G P Boivin; I Ormsby; J Jones-Carson; B A O'Toole; T Doetschman
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

10.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.